Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Taiwanese women with PCOS experience different symptoms based on age, with younger women facing more hormone imbalances and older women dealing with more metabolic issues.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

Estrogen and prolactin may play bigger roles in female hair loss than previously thought.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Alternative treatments show promise for hair growth beyond traditional methods.

About 5% of Thai university girls aged 17-19 have polycystic ovary syndrome, with moderate acne being a strong risk factor.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Acne and increased body hair in teenage girls are normal but severe cases may need hormone evaluation and treatment can prevent diabetes linked to PCO.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

Hirsutism is common body hair growth due to genetics and hormones, and while not a disease, it can be distressing; virilisation includes hirsutism with other male traits and needs medical attention.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Lower vaspin levels in the blood may indicate a better response to fertility treatment in women with PCOS.

Aquaporins could be new drug targets for treating polycystic ovary syndrome.

Finasteride negatively affects fish reproduction and gonadal development.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.